Literature DB >> 18942291

The expression of p53 in invasive ductal carcinoma of the breast: a study in the North-East States of Malaysia.

F S Al-Joudi1, Z A Iskandar, J Rusli.   

Abstract

The p53 gene is a tumour suppressor gene that encodes a 393-amino-acid nuclear DNA-binding phosphoprotein. The significance of p53 detection is that p53 mutation is linked with chemo-resistance and transformation to more aggressive disease in a large number of tumour types and it was confirmed that mutant p53 is involved in neoplastic transformations. In addition, the expression of p53 has been closely correlated with clinicopathological findings. Since breast cancer has been reported as one of the most frequent malignancies in women in Malaysia, the expression of p53 was studied in 382 cases of invasive ductal carcinoma of the breast, obtained from three major hospitals in the North-East States of Malaysia. The study utilized an enzyme immunohistochemistry assay for the detection of p53. It was found that p53 was expressed in 29.6% of all the study cases. Furthermore, its expression was significantly correlated with the age and the clinical grading of the disease. No significant statistical correlations were depicted with lymph node status, tumour size, side of tumour, and expression of estrogen and progesterone receptors. Nevertheless, knowledge of the p53 status may be valuable in making clinical decisions regarding diagnosis, prognosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18942291

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  7 in total

1.  SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.

Authors:  Shu-Jing Yu; Jie-Kai Yu; Wei-Ting Ge; Han-Guang Hu; Ying Yuan; Shu Zheng
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

2.  Alterations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications.

Authors:  Caigang Liu; Hao Zhang; Chen Shuang; Yang Lu; Feng Jin; Huimian Xu; Ping Lu
Journal:  Med Oncol       Date:  2009-08-06       Impact factor: 3.064

3.  Evaluation of p53, HoxD10, and E-Cadherin Status in Breast Cancer and Correlation with Histological Grade and Other Prognostic Factors.

Authors:  Preethi Sekar; Jyotsna Naresh Bharti; Jitendra Singh Nigam; Ankit Sharma; Priyanka Bhatia Soni
Journal:  J Oncol       Date:  2014-01-30       Impact factor: 4.375

4.  Determination of expression profile of p53 gene in different grades of breast cancer tissues by real time PCR.

Authors:  Haleema Sadia; Munir Ahmad Bhinder; Asma Irshad; Beenish Zahid; Rais Ahmed; Sana Ashiq; Kausar Malik; Muhammad Riaz; Tariq Nadeem; Kanwal Ashiq; Ali Akbar
Journal:  Afr Health Sci       Date:  2020-09       Impact factor: 0.927

5.  Mutant p53 protein expression and antioxidant status deficiency in breast cancer.

Authors:  Zorka Milicevic; Jelena Kasapovic; Ljubica Gavrilovic; Zorka Milovanovic; Vladan Bajic; Biljana Spremo-Potparevic
Journal:  EXCLI J       Date:  2014-06-23       Impact factor: 4.068

6.  Systematic review of breast cancer biology in developing countries (part 2): asian subcontinent and South East Asia.

Authors:  Riyaz Bhikoo; Sanket Srinivasa; Tzu-Chieh Yu; David Moss; Andrew G Hill
Journal:  Cancers (Basel)       Date:  2011-05-13       Impact factor: 6.639

7.  Identification of p53 and its isoforms in human breast carcinoma cells.

Authors:  Zorka Milićević; Vladan Bajić; Lada Živković; Jelena Kasapović; Uroš Andjelković; Biljana Spremo-Potparević
Journal:  ScientificWorldJournal       Date:  2014-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.